Quinapril Tablets USP, 20 mg (90 pack), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, by: Lupin Limited, Goa 403 722 India, NDC# 68180-558-09
Published December 28, 2022 · Recall initiated: December 7, 2022
Summary
FDA records drug Class II recall D-0089-2023, published December 28, 2022 and initiated December 7, 2022. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 23,736; Lot: Lot #: G102929, Exp 04/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.
What to do
Voluntary: Firm initiated · Letter
Get an email if QUINAPRIL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- QUINAPRIL
- Manufacturer
- Lupin Pharmaceuticals Inc.
- Distributor
- Product was distributed by major distribution chains nationwide.
- UPC
- 0368180559092
- Lot
- Lot #: G102929, Exp 04/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAQuinapril Tablets USP, 40 mg (90 pack), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore,December 28, 2022
- FDAEGA 22 oz Pizza Dough Ball, 20 ct/ case; frozen pizza doughDecember 28, 2022
- FDAGlycopyrrolate Tablets, USP, 1 mg, 100 tablets, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., EastDecember 28, 2022
- FDAQuinapril Tablets USP 5 mg, 90 count bottles, Lupin Pharmaceuticals, Inc., Baltimore, MD --- NDC 68180-556-09April 12, 2017
- FDAQuinapril Tablets USP, 10 mg, 90 count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc.,January 22, 2014
- FDAQuinapril Tablets USP, 5 mg, 90 count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc.,January 22, 2014
Questions about this recall
Was Quinapril Tablets USP, 20 mg (90 pack), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, by: Lupin Limited, Goa 403 722 India, NDC# 68180-558-09 recalled?
Yes. FDA published recall D-0089-2023 on December 28, 2022. Reported hazard: CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: QUINAPRIL. UPC: 0368180559092.